Insider Selling: Heartflow (NASDAQ:HTFL) CEO Sells $607,773.60 in Stock

Heartflow, Inc. (NASDAQ:HTFL) CEO John C.M. Farquhar sold 15,560 shares of the company’s stock in a transaction dated Friday, August 14th. The stock was sold at an average price of $39.06, for a total transaction of $607,773.60. Following the completion of the sale, the chief executive officer directly owned 420,720 shares in the company, valued at $16,433,323.20. This represents a 3.57% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

John C.M. Farquhar also recently made the following trade(s):

• On Tuesday, August 18th, John C.M. Farquhar sold 32,676 shares of Heartflow stock. The stock was sold at an average price of $45.00, for a total transaction of $1,470,420.00.
• On Monday, August 10th, John C.M. Farquhar sold 22,562 shares of Heartflow stock. The stock was sold at an average price of $28.31, for a total transaction of $638,730.22.
• On Friday, July 10th, John C.M. Farquhar sold 22,562 shares of Heartflow stock. The stock was sold at an average price of $27.75, for a total transaction of $626,095.50.
• On Wednesday, June 24th, John C.M. Farquhar sold 38,900 shares of Heartflow stock. The shares were sold at an average price of $35.00, for a total transaction of $1,361,500.00.
• On Wednesday, June 10th, John C.M. Farquhar sold 22,562 shares of Heartflow stock. The shares were sold at an average price of $28.50, for a total transaction of $643,017.00.

Heartflow Stock Up 2.8%

Shares of HTFL opened at $46.80 on Friday. The stock has a market cap of $4.07 billion and a P/E ratio of -25.57. The business’s 50 day moving average price is $30.33 and its 200-day moving average price is $28.17. Heartflow, Inc. has a 52 week low of $20.13 and a 52 week high of $47.95.

Heartflow (NASDAQ:HTFL) last posted its quarterly earnings data on Thursday, August 13th. The company reported ($0.07) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.22) by $0.15. The company had revenue of $64.08 million during the quarter. Heartflow had a negative return on equity of 23.52% and a negative net margin of 55.82%.The firm’s revenue was up 47.7% on a year-over-year basis. On average, equities analysts anticipate that Heartflow, Inc. will post -0.82 EPS for the current year.

Analysts Set New Price Targets

Several equities analysts have recently issued reports on HTFL shares. Freedom Capital raised Heartflow to a “strong-buy” rating in a research report on Tuesday, June 30th. Stifel Nicolaus increased their price objective on shares of Heartflow from $40.00 to $45.00 and gave the company a “buy” rating in a research report on Friday, August 14th. Canaccord Genuity Group lifted their target price on shares of Heartflow from $37.00 to $45.00 and gave the stock a “buy” rating in a report on Friday, August 14th. JPMorgan Chase & Co. upped their target price on shares of Heartflow from $35.00 to $45.00 and gave the stock an “overweight” rating in a research note on Friday, August 14th. Finally, Wells Fargo & Company increased their price target on shares of Heartflow from $37.00 to $39.00 and gave the company an “overweight” rating in a report on Friday, August 14th. One investment analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $43.43.

Institutional Investors Weigh In On Heartflow

Large investors have recently bought and sold shares of the business. Vanguard Group Inc. purchased a new position in Heartflow in the 3rd quarter worth about $48,871,000. Legal & General Group Plc purchased a new stake in shares of Heartflow during the 3rd quarter valued at about $59,000. Franklin Resources Inc. purchased a new stake in shares of Heartflow during the 3rd quarter valued at about $10,829,000. UBS Group AG bought a new stake in shares of Heartflow in the third quarter worth approximately $5,130,000. Finally, Sei Investments Co. purchased a new position in shares of Heartflow during the third quarter valued at approximately $303,000.

Heartflow Company Profile

HeartFlow, Inc (NASDAQ: HTFL) is a medical technology company that develops non-invasive diagnostic solutions for coronary artery disease. The company’s core offering translates coronary CT angiography (CTA) data into a patient-specific, three-dimensional physiological model of the coronary arteries. Using advanced image processing and computational modeling, HeartFlow’s analysis estimates fractional flow reserve (FFR) values throughout the coronary tree to identify ischemia-producing lesions without the need for invasive pressure-wire measurements.

HeartFlow’s cloud-based service integrates with clinical workflows: clinicians submit coronary CTA images and receive a detailed, color-coded 3D map and report that highlights lesion-specific FFR values and physiological impact.